GlassScriptPhysician profile
Robert Joseph Moraca
NPI 1164455432
$12,113.21
in general payments reported to CMS, 2019-2025
9 companies · $1,450 in 2025
The $1,450 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.20 · 2020: $305 · 2021: $1,045 · 2022: $7,519 · 2023: $1,335 · 2024: $363 · 2025: $1,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,395 · Travel and Lodging: $752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,395.07 |
| Travel and Lodging | $752.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $7,957.25 | 2021-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $2,755.76 | 2021-2025 | Avalus, Corevalve Evolut R, Simulus |
| Abbott Laboratories | $416.09 | 2023-2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic Vascular, INC. | $402.35 | 2019-2020 | |
| Abiomed | $161.24 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $160.08 | 2022-2023 | Camzyos |
| Boston Scientific Corporation | $96.24 | 2021 | |
| Edwards Lifesciences Corporation | $86.77 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Moraca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.